Fatimata Hassane Djibo^1,3*, Maman Daou^2,4, Moudassir Mahamat Ahmat^1,2, Seyni Issa Ousmane¹, Souleymane Brah², Adamou Hassane Aboubacar², Kelani Aminath Bariath⁴, Djibo Douma Maiga⁴and Eric Adehossi Omar⁴

¹Department of Neurology of the Nation Hospital in Niamey, Niger
²Department of Internal Medicine of the National Hospital of Niamei, Niger
³Department of Neurology of Amirou Boubacar Hospital DIALLO, Niger
⁴Faculty of Health Sciences of the University of Abdou Moumouni in Niemey, Niger

*Corresponding Author: Fatimata Hassane Djibo, Department of Neurology of the Nation Hospital in Niamey, Niger.

Received: May 17, 2024; Published: July 24, 2024

Abstract

Introduction: Headaches are one of the most common symptoms, which lead the patient to consult a general practitioner but also a specialist and in particular a neurologist.

These are generally subjective manifestations that only the patient can express.

Object: To determine the clinical, paraclinical and therapeutic aspects of headaches.

Results: This is a retrospective study of 207 cases at the Niamey National Hospital from January 1, 2017 to December 31, 2018. A female predominance with a rate of 69.1% and sex ratio M / F = 0.4; the average age of our patients was 41 years with extremes of 10 and 91 years. The most represented age group was that of 31 to 40 years (20.3%) against (13%) for that of 21 to 30 years. Primary headaches predominated (53.1%) with a predominance of migraine and also predominated in women (34.8%). Secondary headaches (46.9%). Headaches of moderate intensity were the most common at 4.3%. Frontal headaches were the most represented with 95 cases, i.e. 45.8%, temporal in 9.1% of the cases with a pulsatile pain type (30.4%). The accompanying signs were sensitometer deficits and dizziness in 6, 3% each, nausea followed by photophobia (2.4%). Secondary headache stroke predominated with a rate of 11.1%. Brain scan was the most requested examination. Analgesics were used, then anti-inflammatories. Paracetamol is the first line treatment, followed by NSAIDs, antiepileptics and tricyclic antidepressants.

Conclusion: Headache is a very frequent reason for consultation in our context, which remains a very complex approach for the clinician. It can be a specific semiological entity, it is then called primary headache, or be then sign of a potentially serious or even fatal underlying pathology, it will then be called secondary headache.

 Keywords: Headache, Clinical Aspect; Paraclinical; Treatment

References

1. Appert AD. “Céphalées aiguës aux urgences du CHU de Limoges État des lieux et proposition d’un protocole pour la prise en charge”. Thèse de doctorat en Médecine. Université de Limoges (paris) (2014): 107.
2. ADOUKONOU T A., et al. “Prévalence de la migraine dans une population de travailleurs à Cotonou au bénin”. African Journal of Neurological Sciences1 (2009): 16-23.
3. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 24 (2004): 1-160.
4. Recommandations Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et chez l’enfant : aspects cliniques et économiques. Octobre (2002).
5. Expertise collective. La migraine : connaissances descriptives, traitements et prévention. Paris: INSERM. (1998).
6. Bassole Prisca-Rolande., et al. “LES CEPHALEES EN CONSULTATION EN MILIEU DE TRAVAIL A OUAGADOUGOU (BURKINA FASO): IMPACT SUR LA QUALITE DE VIE ET LE RENDEMENT PROFESSIONNEL DES PATIENTS”. African Journal of Neurological Sciences2 (2017).
7. Sonhaye L., et al. “Aspects tomodensitométriques des céphalées de l’adulte vues au Centre Hospitalier Universitaire du Campus de Lomé, Togo”. La Revue Médicale de Madagascar 1 (2015): 497‑500.
8. Wener J Becker., et al. “Lignes directrices sur la prise en charge en soins primaires des céphalées chez l’adulte”. Canadian Family Physician8 (2015): 353–364.
9. Henry P., et al. “La migraine en France. Etude épidémiologique, impact socio-économique et qualité de vie”. Paris : John libbey Eurotext. (1993).
10. Badda AR. “Etude épidémiologique et clinique des céphalées dans le district de Bamako”. Thèse de doctorat en médecine Université de Bamako (2005): 112.
11. Axel L. “Céphalées aiguës non traumatiques en médecine générale: recours aux urgences à propos de 100 cas recensés au SAU de Trinité”. Thèse de doctorat en médecine Université Hyacinthe BASTARAUD des Antilles et de la Guyane (2016): 112.
12. Steiner TJ. “Atlas of headache disorders and resources in the world in 2011”. OMS (2011).
13. Tapha O. “Nosologie et fréquence des affections neurologiques en consultation externe de neurologie à Niamey”. Thèse de doctorat en médecine Université Abdou Moumouni de Niamey (2011): 199.

Citation

Citation: Fatimata Hassane Djibo., et al. “Clinical, Paraclinical and Therapeutic Aspects of Headaches in the Neurology and Internal Medicine Departments of the National Hospital of Niamey”.Acta Scientific Medical Sciences 8.8 (2024): 198-202.

Copyright

Copyright: © 2024 Fatimata Hassane Djibo., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.